Cargando…

Live Imaging of Immune Responses in Experimental Models of Multiple Sclerosis

Experimental autoimmune encephalomyelitis (EAE) is the most common animal model of multiple sclerosis (MS), a chronic inflammatory autoimmune disease of the central nervous system (CNS) characterized by multifocal perivascular infiltrates that predominantly comprise lymphocytes and macrophages. Duri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Barbara, Constantin, Gabriela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116921/ https://www.ncbi.nlm.nih.gov/pubmed/27917173 http://dx.doi.org/10.3389/fimmu.2016.00506

Ejemplares similares

Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease
por: Rossi, Barbara, et al.
Publicado: (2021)

Pathogenic CD8 T Cells in Multiple Sclerosis and Its Experimental Models
por: Huseby, Eric S., et al.
Publicado: (2012)

Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis
por: Gentile, Antonietta, et al.
Publicado: (2019)

Live Imaging of Innate and Adaptive Immune Responses in the Liver
por: Li, Lu, et al.
Publicado: (2020)

Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple Sclerosis
por: Yandamuri, Soumya S., et al.
Publicado: (2016)

Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota
por: van den Hoogen, Ward J., et al.
Publicado: (2017)

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis
por: Mestre, Leyre, et al.
Publicado: (2019)

CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis
por: Sinha, Sushmita, et al.
Publicado: (2015)

Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Clemente, Nausicaa, et al.
Publicado: (2017)

Multiplexed imaging of immune cells in staged multiple sclerosis lesions by mass cytometry
por: Ramaglia, Valeria, et al.
Publicado: (2019)

CCR6 blockade on regulatory T cells ameliorates experimental model of multiple sclerosis
por: JATCZAK-PAWLIK, IZABELA, et al.
Publicado: (2020)

Mechanistic and Biomarker Studies to Demonstrate Immune Tolerance in Multiple Sclerosis
por: Docampo, María José, et al.
Publicado: (2022)

Association of the retinal vasculature, intrathecal immunity, and disability in multiple sclerosis
por: Noll, Christina, et al.
Publicado: (2022)

Immune cells transcriptome-based drug repositioning for multiple sclerosis
por: Yin, Xinyue, et al.
Publicado: (2022)

Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
por: Elliott, David M., et al.
Publicado: (2018)

Monocytes and Monocyte-Derived Antigen-Presenting Cells Have Distinct Gene Signatures in Experimental Model of Multiple Sclerosis
por: Monaghan, Kelly L., et al.
Publicado: (2019)

Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Arellano, Gabriel, et al.
Publicado: (2015)

Expression of Concern: Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis
Publicado: (2020)

Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination
por: Faissner, Simon, et al.
Publicado: (2022)

Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients
por: Sánchez-Sanz, Alicia, et al.
Publicado: (2023)

The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis
por: Angelini, Gabriele, et al.
Publicado: (2023)

The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Aarts, Suzanne A. B. M., et al.
Publicado: (2017)

Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring
por: Khoy, Kathy, et al.
Publicado: (2020)

Editorial: Environmental factors influencing the immune functions during multiple sclerosis
por: Smolders, Joost, et al.
Publicado: (2023)

Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients
por: Telesford, Kiel M., et al.
Publicado: (2023)

Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes
por: Faber, Hans, et al.
Publicado: (2020)

Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases
por: Riedhammer, Christine, et al.
Publicado: (2015)

A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model
por: ’t Hart, Bert A., et al.
Publicado: (2017)

Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis
por: Marín-Prida, Javier, et al.
Publicado: (2022)

Illumination of Molecular Pathways in Multiple Sclerosis Lesions and the Immune Mechanism of Matrine Treatment in EAE, a Mouse Model of MS
por: Dou, Mengmeng, et al.
Publicado: (2021)

Pattern Recognition Receptors in Multiple Sclerosis and Its Animal Models
por: Deerhake, M. Elizabeth, et al.
Publicado: (2019)

Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models
por: Stamoula, Eleni, et al.
Publicado: (2021)

Fc multimers effectively treat murine models of multiple sclerosis
por: Wang, Jin, et al.
Publicado: (2023)

Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab
por: Groß-Albenhausen, Elina, et al.
Publicado: (2023)

Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption
por: Gröning, Remigius, et al.
Publicado: (2023)

Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
por: Morandi, Elena, et al.
Publicado: (2019)

Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis
por: Li, Rui, et al.
Publicado: (2016)

Acute Thermoregulatory and Cardiovascular Response to Submaximal Exercise in People With Multiple Sclerosis
por: Gervasoni, Elisa, et al.
Publicado: (2022)

Therapeutic Targeting of Immune Cell Autophagy in Multiple Sclerosis: Russian Roulette or Silver Bullet?
por: Yang, Guan, et al.
Publicado: (2021)

Immune Regulatory Cell Bias Following Alemtuzumab Treatment in Relapsing-Remitting Multiple Sclerosis
por: Kashani, Nicole, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vbnfsm5draigkdfua3rii3lljm